NALDEMEDINE TOSYLATE (Rizmoic®)
Clinical Indication
opioid-induced constipation
Date of classification
November 2019
Review date
January 2021
Green
Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.